Sierra Oncology Jumps 36% on $1.9B Acquisition by GlaxoSmithKline
(Sierra Oncology) Shares of Sierra Oncology rose more than 36% in premarket on Wednesday after agreeing to be acquired by Sierra Oncology for $1.9 billion. The deal will see Sierra…
Sierra Oncology